Literature DB >> 31545149

Leptin Induces Hypertension Acting on Transient Receptor Potential Melastatin 7 Channel in the Carotid Body.

Mi-Kyung Shin1, Candela Caballero Eraso2, Yun-Ping Mu3, Chenjuan Gu1, Bonnie H Y Yeung1, Lenise J Kim1,4, Xiao-Ru Liu3, Zhi-Juan Wu3, Omkar Paudel5, Luis E Pichard5, Machiko Shirahata5, Wan-Yee Tang, James S K Sham1, Vsevolod Y Polotsky1.   

Abstract

RATIONALE: Obesity leads to resistant hypertension and mechanisms are poorly understood, but high plasma levels of leptin have been implicated. Leptin increases blood pressure acting both centrally in the dorsomedial hypothalamus and peripherally. Sites of the peripheral hypertensive effect of leptin have not been identified. We previously reported that leptin enhanced activity of the carotid sinus nerve, which transmits chemosensory input from the carotid bodies (CBs) to the medullary centers, and this effect was abolished by nonselective blockers of Trp (transient receptor potential) channels. We searched our mouse CB transcriptome database and found that the Trpm7 (transient receptor potential melastatin 7) channel was the most abundant Trp channel.
OBJECTIVE: To examine if leptin induces hypertension acting on the CB Trpm7. METHODS AND
RESULTS: C57BL/6J (n=79), leptin receptor (LepRb) deficient db/db mice (n=22), and LepRb-EGFP (n=4) mice were used. CB Trpm7 and LepRb gene expression was determined and immunohistochemistry was performed; CB glomus cells were isolated and Trpm7-like current was recorded. Blood pressure was recorded continuously in (1) leptin-treated C57BL/6J mice with intact and denervated CB; (2) leptin-treated C57BL/6J mice, which also received a nonselective Trpm7 blocker FTY720 administered systemically or topically to the CB area; (3) leptin-treated C57BL/6J mice transfected with Trpm7 small hairpin RNA to the CB, and (4) Leprb deficient obese db/db mice before and after Leprb expression in CB. Leptin receptor and Trpm7 colocalized in the CB glomus cells. Leptin induced a nonselective cation current in these cells, which was inhibited by Trpm7 blockers. Leptin induced hypertension in C57BL/6J mice, which was abolished by CB denervation, Trpm 7 blockers, and Trpm7 small hairpin RNA applied to CBs. Leprb overexpression in CB of Leprb-deficient db/db mice demethylated the Trpm7 promoter, increased Trpm7 gene expression, and induced hypertension.
CONCLUSIONS: We conclude that leptin induces hypertension acting on Trmp7 in CB, which opens horizons for new therapy.

Entities:  

Keywords:  carotid body; hypertension; leptin; obesity; transient receptor potential channels

Mesh:

Substances:

Year:  2019        PMID: 31545149      PMCID: PMC6842127          DOI: 10.1161/CIRCRESAHA.119.315338

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  65 in total

Review 1.  Obesity-associated hypertension: new insights into mechanisms.

Authors:  Kamal Rahmouni; Marcelo L G Correia; William G Haynes; Allyn L Mark
Journal:  Hypertension       Date:  2004-12-06       Impact factor: 10.190

Review 2.  Molecular and neural mediators of leptin action.

Authors:  Scott A Robertson; Gina M Leinninger; Martin G Myers
Journal:  Physiol Behav       Date:  2008-04-13

3.  Activation of TRPM7 channels by small molecules under physiological conditions.

Authors:  T Hofmann; S Schäfer; M Linseisen; L Sytik; T Gudermann; V Chubanov
Journal:  Pflugers Arch       Date:  2014-03-15       Impact factor: 3.657

Review 4.  Function and regulation of the channel-kinase TRPM7 in health and disease.

Authors:  Daan Visser; Jeroen Middelbeek; Frank N van Leeuwen; Kees Jalink
Journal:  Eur J Cell Biol       Date:  2014-07-08       Impact factor: 4.492

5.  Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7.

Authors:  V Chubanov; M Mederos y Schnitzler; M Meißner; S Schäfer; K Abstiens; T Hofmann; T Gudermann
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 6.  Signal processing at mammalian carotid body chemoreceptors.

Authors:  Colin A Nurse; Nikol A Piskuric
Journal:  Semin Cell Dev Biol       Date:  2012-09-26       Impact factor: 7.727

7.  A search for genes that may confer divergent morphology and function in the carotid body between two strains of mice.

Authors:  Alexander Balbir; Hannah Lee; Mariko Okumura; Shyam Biswal; Robert S Fitzgerald; Machiko Shirahata
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-11-10       Impact factor: 5.464

8.  Quantifying hypoxia-induced chemoreceptor sensitivity in the awake rodent.

Authors:  Barbara J Morgan; Russell Adrian; Melissa L Bates; John M Dopp; Jerome A Dempsey
Journal:  J Appl Physiol (1985)       Date:  2014-07-31

9.  The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension.

Authors:  Fiona D McBryde; Ana P Abdala; Emma B Hendy; Wioletta Pijacka; Paul Marvar; Davi J A Moraes; Paul A Sobotka; Julian F R Paton
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  TRPM7 regulates proliferation and polarisation of macrophages.

Authors:  Tom Schilling; Francesc Miralles; Claudia Eder
Journal:  J Cell Sci       Date:  2014-09-09       Impact factor: 5.285

View more
  20 in total

1.  Neuronal Networks in Hypertension: Recent Advances.

Authors:  Patrice G Guyenet; Ruth L Stornetta; George M P R Souza; Stephen B G Abbott; Virginia L Brooks
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

2.  Leptin Activates Trpm7 Channels in the Carotid Body As a Mechanism of Obesity-Related Hypertension.

Authors:  Fang Zheng; Shengyu Mu; Nancy J Rusch
Journal:  Circ Res       Date:  2019-11-07       Impact factor: 17.367

Review 3.  Leptin-mediated neural targets in obesity hypoventilation syndrome.

Authors:  Mateus R Amorim; O Aung; Babak Mokhlesi; Vsevolod Y Polotsky
Journal:  Sleep       Date:  2022-09-08       Impact factor: 6.313

Review 4.  Are Multiple Mitochondrial Related Signalling Pathways Involved in Carotid Body Oxygen Sensing?

Authors:  Andrew P Holmes; Agnieszka Swiderska; Demitris Nathanael; Hayyaf S Aldossary; Clare J Ray; Andrew M Coney; Prem Kumar
Journal:  Front Physiol       Date:  2022-05-31       Impact factor: 4.755

Review 5.  Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism.

Authors:  Sandra Pereira; Daemon L Cline; Maria M Glavas; Scott D Covey; Timothy J Kieffer
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

6.  Leptin Induces Epigenetic Regulation of Transient Receptor Potential Melastatin 7 in Rat Adrenal Pheochromocytoma Cells.

Authors:  Bonnie Ho-Yee Yeung; Kelly Griffiths; Liron Berger; Omkar Paudel; Mi-Kyung Shin; Liangyou Rui; James S K Sham; Vsevolod Y Polotsky; Wan-Yee Tang
Journal:  Am J Respir Cell Mol Biol       Date:  2021-08       Impact factor: 6.914

7.  Pharmacological and Genetic Blockade of Trpm7 in the Carotid Body Treats Obesity-Induced Hypertension.

Authors:  Mi-Kyung Shin; Roxana Mitrut; Chenjuan Gu; Lenise J Kim; Bonnie H Y Yeung; Rachel Lee; Luu Pham; Wan-Yee Tang; James S K Sham; Honggang Cui; Vsevolod Y Polotsky
Journal:  Hypertension       Date:  2021-05-17       Impact factor: 9.897

Review 8.  Carotid body chemoreceptors: physiology, pathology, and implications for health and disease.

Authors:  Rodrigo Iturriaga; Julio Alcayaga; Mark W Chapleau; Virend K Somers
Journal:  Physiol Rev       Date:  2021-02-11       Impact factor: 46.500

9.  Importance of the renal ion channel TRPM6 in the circadian secretion of renin to raise blood pressure.

Authors:  Yosuke Funato; Daisuke Yamazaki; Daisuke Okuzaki; Nobuhiko Yamamoto; Hiroaki Miki
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

10.  Leptin Receptor Blockade Attenuates Hypertension, but Does Not Affect Ventilatory Response to Hypoxia in a Model of Polygenic Obesity.

Authors:  Lenise J Kim; Mi-Kyung Shin; Huy Pho; Laszlo Otvos; Sergio Tufik; Monica L Andersen; Luu V Pham; Vsevolod Y Polotsky
Journal:  Front Physiol       Date:  2021-07-02       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.